Albert Labs International Corp.
Albert Labs International Corp. is a research and drug development company addressing mental health care needs. Through a succinct clinical pathway, focusing on Real World Evidence (RWE) Albert Labs look to commercialize its psychedelic-based treatments, and in doing so deliver psychedelic-assisted psychotherapy to patients sooner. Focused on accelerating access and faster approvals, Albert Labs put patients with urgent and unmet needs first as it develops licensed medicines to treat a variety of mental health conditions. Cancer-related distress, an initial focus of Albert Labs development program is thought to affect over 16 million patients worldwide.
Albert Labs International Corp. (ABRT)
le 7 juillet/July 2023
Effective immediately, Albert Labs International Corp. will be reinstated for trading.
The Company has rectified the situation that gave rise to the suspension.